The Aroon Indicator for XLI entered a downward trend on October 16, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 131 similar instances where the Aroon Indicator formed such a pattern. In 110 of the 131 cases the stock moved lower. This puts the odds of a downward move at 84%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 57 cases where XLI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 77%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XLI as a result. In 66 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.
The 50-day moving average for XLI moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XLI's RSI Oscillator exited the oversold zone, 22 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for XLI just turned positive on September 23, 2026. Looking at past instances where XLI's MACD turned positive, the stock continued to rise in 39 of 46 cases over the following month. The odds of a continued upward trend are 85%.
Following a +0.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where XLI advanced for three days, in 279 of 336 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
XLI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
| WDAF | XLI | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 85% |
| Stochastic ODDS (%) | N/A | 2 days ago 77% |
| Momentum ODDS (%) | N/A | 2 days ago 74% |
| MACD ODDS (%) | N/A | 2 days ago 85% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 82% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 81% |
| Advances ODDS (%) | N/A | 3 days ago 83% |
| Declines ODDS (%) | N/A | 5 days ago 78% |
| BollingerBands ODDS (%) | N/A | 2 days ago 89% |
| Aroon ODDS (%) | N/A | 2 days ago 84% |
A.I.dvisor indicates that over the last year, XLI has been closely correlated with EMR. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if XLI jumps, then EMR could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NAD | 10.46 | 0.14 | +1.36% |
| Nuveen Quality Municipal Income Fund | |||
| QQXT | 100.16 | 0.32 | +0.32% |
| First Trust Nasdaq-100 Ex-Technology Sector Index Fund (QQXT) | |||
| BBC | 42.13 | -0.28 | -0.67% |
| Virtus Biotech Clinical Trials ETF (BBC) | |||
| HSBH | 101.85 | -2.24 | -2.15% |
| HSBC HOLDINGS PLC ADRHEDGED | |||
| GRNJ | 25.92 | -1.45 | -5.30% |
| Fundstrat Granny Shots US Small & Mid Cap ETF | |||